What is a stock summary page? Click here for an overview.
Business Description
Vanta Bioscience Ltd
ISIN : INE695X01011
Share Class Description:
BOM:540729: Ordinary SharesCompare
Compare
Traded in other countries / regions
540729.India IPO Date
2017-10-06Description
Vanta Bioscience Ltd is a full-service preclinical contract research organization. It is engaged in the provision of testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research, and environmental studies. It offers toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation services.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.16 | |||||
| Debt-to-Equity | 4.83 | |||||
| Debt-to-EBITDA | -63.08 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -0.08 | |||||
| Beneish M-Score | -2.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.1 | |||||
| 3-Year EBITDA Growth Rate | -29 | |||||
| 3-Year FCF Growth Rate | 63.8 | |||||
| 3-Year Book Growth Rate | -14 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.68 | |||||
| 9-Day RSI | 31.03 | |||||
| 14-Day RSI | 33.09 | |||||
| 3-1 Month Momentum % | -32.37 | |||||
| 6-1 Month Momentum % | -41.16 | |||||
| 12-1 Month Momentum % | -60.3 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.74 | |||||
| Quick Ratio | 0.36 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 3562.65 | |||||
| Days Sales Outstanding | 203.78 | |||||
| Days Payable | 2375.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -52.13 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 129.01 | |||||
| Operating Margin % | -125.74 | |||||
| Net Margin % | -84.07 | |||||
| FCF Margin % | -93.15 | |||||
| ROE % | -25.2 | |||||
| ROA % | -4.52 | |||||
| ROIC % | -6.7 | |||||
| 3-Year ROIIC % | -25.04 | |||||
| ROC (Joel Greenblatt) % | -17.64 | |||||
| ROCE % | -8.93 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.86 | |||||
| PB Ratio | 0.96 | |||||
| EV-to-EBIT | -13.1 | |||||
| EV-to-EBITDA | -71.37 | |||||
| EV-to-Revenue | 16.27 | |||||
| EV-to-FCF | -17.47 | |||||
| Price-to-GF-Value | 0.22 | |||||
| Earnings Yield (Greenblatt) % | -7.63 | |||||
| FCF Yield % | -32.54 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vanta Bioscience Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 45.775 | ||
| EPS (TTM) (₹) | -6.1 | ||
| Beta | 0.6 | ||
| 3-Year Sharpe Ratio | -0.54 | ||
| 3-Year Sortino Ratio | -0.87 | ||
| Volatility % | 44.15 | ||
| 14-Day RSI | 33.09 | ||
| 14-Day ATR (₹) | 0.885162 | ||
| 20-Day SMA (₹) | 22.1725 | ||
| 12-1 Month Momentum % | -60.3 | ||
| 52-Week Range (₹) | 19.7 - 75.24 | ||
| Shares Outstanding (Mil) | 6.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vanta Bioscience Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vanta Bioscience Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vanta Bioscience Ltd Frequently Asked Questions
What is Vanta Bioscience Ltd(BOM:540729)'s stock price today?
The current price of BOM:540729 is ₹20.76. The 52 week high of BOM:540729 is ₹75.24 and 52 week low is ₹19.70.
When is next earnings date of Vanta Bioscience Ltd(BOM:540729)?
The next earnings date of Vanta Bioscience Ltd(BOM:540729) is .
Does Vanta Bioscience Ltd(BOM:540729) pay dividends? If so, how much?
Vanta Bioscience Ltd(BOM:540729) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers